An open label study to evaluate the safety, and effect on treatment response, of MabThera in combination with methotrexate in patients with active rheumatoid arthritis who have had an inadequate response or intolerance to one or more anti-TNF agents.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 21 May 2012 Actual end date Apr 2010 added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.